Meanwhile, CYP19A1 is upregulated in the ER positive cell lines (MCF-7, BT-474) of all the 5 breast cancer cell lines, with the highest expression in BT-474, while almost no expression in ER negative breast cancer cell lines (Figure 1B, 1C). This evidence concerns the gene CYP19A1 and breast carcinoma.